Radiolabelling of nanomaterials for medical imaging and therapy
Nanomaterials offer unique physical, chemical and biological properties of interest for
medical imaging and therapy. Over the last two decades, there has been an increasing effort …
medical imaging and therapy. Over the last two decades, there has been an increasing effort …
[HTML][HTML] Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticles
The objective of this manuscript is to provide quantitative insights into the tissue distribution
of nanoparticles. Published pharmacokinetics of nanoparticles in plasma, tumor and 13 …
of nanoparticles. Published pharmacokinetics of nanoparticles in plasma, tumor and 13 …
[HTML][HTML] Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine
The integration of nuclear imaging with nanomedicine is a powerful tool for efficient
development and clinical translation of liposomal drug delivery systems. Furthermore, it may …
development and clinical translation of liposomal drug delivery systems. Furthermore, it may …
DSPE-PEG: a distinctive component in drug delivery system
J Che, CI Okeke, ZB Hu, J Xu - Current pharmaceutical design, 2015 - ingentaconnect.com
1, 2-Distearoyl-sn-glycero-3-phosphoethanolamine-Poly (ethylene glycol)(DSPE-PEG) is a
widely used phospholipids-polymer conjugate in drug delivery applications. It is a …
widely used phospholipids-polymer conjugate in drug delivery applications. It is a …
Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines
S Edmonds, A Volpe, H Shmeeda… - ACS …, 2016 - ACS Publications
The clinical value of current and future nanomedicines can be improved by introducing
patient selection strategies based on noninvasive sensitive whole-body imaging techniques …
patient selection strategies based on noninvasive sensitive whole-body imaging techniques …
Copper radiopharmaceuticals for theranostic applications
A Ahmedova, B Todorov, N Burdzhiev… - European Journal of …, 2018 - Elsevier
The growing advancement in nuclear medicine challenges researchers from several
different fields to integrate imaging and therapeutic modalities in a theranostic …
different fields to integrate imaging and therapeutic modalities in a theranostic …
Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies
S Shi, M Zhou, X Li, M Hu, C Li, M Li, F Sheng… - Journal of Controlled …, 2016 - Elsevier
Conventional enhanced permeation and retention (EPR) mediates the effects of many
drugs, including the accumulation of nanocarriers at tumor sites, but its efficiency remains …
drugs, including the accumulation of nanocarriers at tumor sites, but its efficiency remains …
Nanoparticles and radioisotopes: a long story in a nutshell
G Poletto, L Evangelista, F Venturini, F Gramegna… - Pharmaceutics, 2022 - mdpi.com
The purpose of this narrative review was to assess the use of nanoparticles (NPs) to deliver
radionuclides to targets, focusing on systems that have been tested in pre-clinical and, when …
radionuclides to targets, focusing on systems that have been tested in pre-clinical and, when …
[HTML][HTML] Analytical methods for investigating in vivo fate of nanoliposomes: A review
C Su, Y Liu, Y He, J Gu - Journal of pharmaceutical analysis, 2018 - Elsevier
Nanoliposomes are considered to be the most successful nanoparticle drug delivery system,
but their fate in vivo has not been fully understood due to lack of reliable bioanalytical …
but their fate in vivo has not been fully understood due to lack of reliable bioanalytical …
Ligand decorated biodegradable nanomedicine in the treatment of cancer
Cancer is one of the major global health problems, responsible for the second-highest
number of deaths. The genetic and epigenetic changes in the oncogenes or tumor …
number of deaths. The genetic and epigenetic changes in the oncogenes or tumor …